- Investor Presentation
- Licence Agreement in Canada for AccruferÂ®
- Second Price Monitoring Extn
- Price Monitoring Extension
- Patient Access Expands for AccruferÂ®
- Block Listing 6 Monthly Return
- Jose A. Menoyo Appointed as Chief Medical Officer
- Investor presentation
- PDMR Transaction Notification
- Half-year Report
Shield Therapeutics PLC (SHIEF:QXE) closed at 0.477, 8.66% above its 52-week low of 0.439, set on Dec 09, 2021.
0.439Dec 09 20211.50Mar 10 2021
Markit short selling activity
|Market cap||75.33m GBP|
|EPS (TTM)||-0.0817 |
Data delayed at least 15 minutes, as of Jan 24 2022.